BioSpace News Archive

ACADIA plans to initiate a Phase 3 study of trofinetide for the treatment of Rett syndrome, a rare neurodevelopmental congenital CNS disorder, in the second half of 2019

Telemedicine Platform Expands Access to Prescription Birth Control and PrEP for HIV Prevention To Combat Tennessee’s Unintended Pregnancy Rate and HIV Cases

National Kidney Foundation (NKF) has selected five doctors from throughout the country to be award recipients of the 2018 NKF Young Investigator Research Grant Program

Exclusive license agreement potentially worth more than $120 million in addition to royalties

Ascletis Pharma Inc. (1672.HK) announced today Ravidasvir is recommended by the World Health Organization (WHO) Guidelines for the Care and Treatment of Persons Diagnosed with Chronic Hepatitis C Virus Infection (July 2018) as a future pan-genotypic direct-acting antivirals agent (DAA). Ascletis received the acceptance letter for Ravidasvir new drug application (NDA) from the China Food and Drug Administration (CFDA) on August 1.

This pre-clinical study examines the Immunotoxicology and anti-inflammatory properties of GB Sciences’ Cannabis-Containing Complex Formulas for Parkinson’s Disease in preparation for their clinical trial.

The collaborators will specifically leverage Regeneron’s VelociSuite® platform technologies for the discovery and characterization of fully human antibodies

First USFDA approved, extended-release sprinkle formulation of metoprolol succinate indicated for treatment of patients with Hypertension, Angina Pectoris and Heart Failure

Investment of £20 Million for Eight UK Universities Includes Two 1 GHz Systems

Dr. Litton joins Alpine from Alder BioPharmaceuticals, where he has served as Chief Business Officer and Treasurer since co-founding the company in 2004.